SUMO1 negatively regulates reactive oxygen species production from NADPH oxidases

Deepesh Pandey, Feng Chen, Anand Patel, Cong Yi Wang, Christiana Dimitropoulou, Vijaykumar Surendrakant Patel, Radu Daniel Rudic, David W Stepp, David J Fulton

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Objective-: Increased protein SUMOylation (small ubiquitin-related modifier [SUMO]) provides protection from cellular stress, including oxidative stress, but the mechanisms involved are incompletely understood. The NADPH oxidases (Nox) are a primary source of reactive oxygen species (ROS) and oxidative stress, and thus our goal was to determine whether SUMO regulates NADPH oxidase activity. Methods and Results-: Increased expression of SUMO1 potently inhibited the activity of Nox1 to Nox5. In contrast, inhibition of endogenous SUMOylation with small interfering RNA to SUMO1 or ubiquitin conjugating enzyme 9 or with the inhibitor anacardic acid increased ROS production from human embryonic kidney-Nox5 cells, human vascular smooth muscle cells, and neutrophils. The suppression of ROS production was unique to SUMO1, and it required a C-terminal diglycine and the SUMO-specific conjugating enzyme ubiquitin conjugating enzyme 9. SUMO1 did not modify intracellular calcium or Nox5 phosphorylation but reduced ROS output in an isolated enzyme assay, suggesting direct effects of SUMOylation on enzyme activity. However, we could not detect the presence of SUMO1 conjugation on Nox5 using a variety of approaches. Moreover, the mutation of more than 17 predicted and conserved lysine residues on Nox5 did not alter the inhibitory actions of SUMO1. Conclusion-: Together, these results suggest that SUMO is an important regulatory mechanism that indirectly represses the production of ROS to ameliorate cellular stress.

Original languageEnglish (US)
Pages (from-to)1634-1642
Number of pages9
JournalArteriosclerosis, thrombosis, and vascular biology
Volume31
Issue number7
DOIs
StatePublished - Jul 1 2011

Fingerprint

NADPH Oxidase
Reactive Oxygen Species
Sumoylation
Ubiquitin
Ubiquitin-Conjugating Enzymes
Small Ubiquitin-Related Modifier Proteins
Oxidative Stress
Glycylglycine
Enzyme Assays
Vascular Smooth Muscle
Small Interfering RNA
Lysine
Smooth Muscle Myocytes
Neutrophils
Phosphorylation
Calcium
Kidney
Mutation
Enzymes

Keywords

  • endothelium
  • reactive oxygen species
  • signal transduction
  • stress
  • vascular biology

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

SUMO1 negatively regulates reactive oxygen species production from NADPH oxidases. / Pandey, Deepesh; Chen, Feng; Patel, Anand; Wang, Cong Yi; Dimitropoulou, Christiana; Patel, Vijaykumar Surendrakant; Rudic, Radu Daniel; Stepp, David W; Fulton, David J.

In: Arteriosclerosis, thrombosis, and vascular biology, Vol. 31, No. 7, 01.07.2011, p. 1634-1642.

Research output: Contribution to journalArticle

@article{f5b566e94e8448e691902a08360dec13,
title = "SUMO1 negatively regulates reactive oxygen species production from NADPH oxidases",
abstract = "Objective-: Increased protein SUMOylation (small ubiquitin-related modifier [SUMO]) provides protection from cellular stress, including oxidative stress, but the mechanisms involved are incompletely understood. The NADPH oxidases (Nox) are a primary source of reactive oxygen species (ROS) and oxidative stress, and thus our goal was to determine whether SUMO regulates NADPH oxidase activity. Methods and Results-: Increased expression of SUMO1 potently inhibited the activity of Nox1 to Nox5. In contrast, inhibition of endogenous SUMOylation with small interfering RNA to SUMO1 or ubiquitin conjugating enzyme 9 or with the inhibitor anacardic acid increased ROS production from human embryonic kidney-Nox5 cells, human vascular smooth muscle cells, and neutrophils. The suppression of ROS production was unique to SUMO1, and it required a C-terminal diglycine and the SUMO-specific conjugating enzyme ubiquitin conjugating enzyme 9. SUMO1 did not modify intracellular calcium or Nox5 phosphorylation but reduced ROS output in an isolated enzyme assay, suggesting direct effects of SUMOylation on enzyme activity. However, we could not detect the presence of SUMO1 conjugation on Nox5 using a variety of approaches. Moreover, the mutation of more than 17 predicted and conserved lysine residues on Nox5 did not alter the inhibitory actions of SUMO1. Conclusion-: Together, these results suggest that SUMO is an important regulatory mechanism that indirectly represses the production of ROS to ameliorate cellular stress.",
keywords = "endothelium, reactive oxygen species, signal transduction, stress, vascular biology",
author = "Deepesh Pandey and Feng Chen and Anand Patel and Wang, {Cong Yi} and Christiana Dimitropoulou and Patel, {Vijaykumar Surendrakant} and Rudic, {Radu Daniel} and Stepp, {David W} and Fulton, {David J}",
year = "2011",
month = "7",
day = "1",
doi = "10.1161/ATVBAHA.111.226621",
language = "English (US)",
volume = "31",
pages = "1634--1642",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - SUMO1 negatively regulates reactive oxygen species production from NADPH oxidases

AU - Pandey, Deepesh

AU - Chen, Feng

AU - Patel, Anand

AU - Wang, Cong Yi

AU - Dimitropoulou, Christiana

AU - Patel, Vijaykumar Surendrakant

AU - Rudic, Radu Daniel

AU - Stepp, David W

AU - Fulton, David J

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Objective-: Increased protein SUMOylation (small ubiquitin-related modifier [SUMO]) provides protection from cellular stress, including oxidative stress, but the mechanisms involved are incompletely understood. The NADPH oxidases (Nox) are a primary source of reactive oxygen species (ROS) and oxidative stress, and thus our goal was to determine whether SUMO regulates NADPH oxidase activity. Methods and Results-: Increased expression of SUMO1 potently inhibited the activity of Nox1 to Nox5. In contrast, inhibition of endogenous SUMOylation with small interfering RNA to SUMO1 or ubiquitin conjugating enzyme 9 or with the inhibitor anacardic acid increased ROS production from human embryonic kidney-Nox5 cells, human vascular smooth muscle cells, and neutrophils. The suppression of ROS production was unique to SUMO1, and it required a C-terminal diglycine and the SUMO-specific conjugating enzyme ubiquitin conjugating enzyme 9. SUMO1 did not modify intracellular calcium or Nox5 phosphorylation but reduced ROS output in an isolated enzyme assay, suggesting direct effects of SUMOylation on enzyme activity. However, we could not detect the presence of SUMO1 conjugation on Nox5 using a variety of approaches. Moreover, the mutation of more than 17 predicted and conserved lysine residues on Nox5 did not alter the inhibitory actions of SUMO1. Conclusion-: Together, these results suggest that SUMO is an important regulatory mechanism that indirectly represses the production of ROS to ameliorate cellular stress.

AB - Objective-: Increased protein SUMOylation (small ubiquitin-related modifier [SUMO]) provides protection from cellular stress, including oxidative stress, but the mechanisms involved are incompletely understood. The NADPH oxidases (Nox) are a primary source of reactive oxygen species (ROS) and oxidative stress, and thus our goal was to determine whether SUMO regulates NADPH oxidase activity. Methods and Results-: Increased expression of SUMO1 potently inhibited the activity of Nox1 to Nox5. In contrast, inhibition of endogenous SUMOylation with small interfering RNA to SUMO1 or ubiquitin conjugating enzyme 9 or with the inhibitor anacardic acid increased ROS production from human embryonic kidney-Nox5 cells, human vascular smooth muscle cells, and neutrophils. The suppression of ROS production was unique to SUMO1, and it required a C-terminal diglycine and the SUMO-specific conjugating enzyme ubiquitin conjugating enzyme 9. SUMO1 did not modify intracellular calcium or Nox5 phosphorylation but reduced ROS output in an isolated enzyme assay, suggesting direct effects of SUMOylation on enzyme activity. However, we could not detect the presence of SUMO1 conjugation on Nox5 using a variety of approaches. Moreover, the mutation of more than 17 predicted and conserved lysine residues on Nox5 did not alter the inhibitory actions of SUMO1. Conclusion-: Together, these results suggest that SUMO is an important regulatory mechanism that indirectly represses the production of ROS to ameliorate cellular stress.

KW - endothelium

KW - reactive oxygen species

KW - signal transduction

KW - stress

KW - vascular biology

UR - http://www.scopus.com/inward/record.url?scp=79959688911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959688911&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.111.226621

DO - 10.1161/ATVBAHA.111.226621

M3 - Article

VL - 31

SP - 1634

EP - 1642

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 7

ER -